X

Newsroom

13-10-2017

Vizulize, Pollenase and Auxifen available at Pharmacies

At Accord, we are committed to providing access to more medicines for our customers and patients.  We are therefore delighted to announce that from October 2017, the following OTC brands; ...

Read more

04-10-2017

Accord Healthcare continues Community Pharmacy support by sponsoring 2017 National Pharmacy Association Conference

On Saturday 7th October 2017 the National Pharmacy Association (NPA) will be holding their annual member conference and Accord Healthcare are excited to be one of the key sponsors.

Read more

03-10-2017

Accord Healthcare further reinforces commitment to being the Partner of Choice for Independent Community Pharmacies.

Accord Healthcare are honoured to once again be sponsoring the Pharmacy Team Learning & Development Award at the 2017 Independent Pharmacy Awards.

Read more

15-09-2017

ACCORD HEALTHCARE BOOSTS PORTFOLIO WITH MYCOPHENOLIC ACID GR TABLETS

In line with Accord Healthcare’s vision to be involved in all aspects of bringing pharmaceuticals to patients, it has launched Mycophenolic Acid GR Tablets 180mg and 360mg.

Read more

12-09-2017

LloydsPharmacy to celebrate success of patient safety programme at annual conference

LloydsPharmacy, part of the Celesio UK family, will hold a conference on 6th September dedicated to their patient safety programme, SaferCare. The event will take place at the Holiday Inn,...

Read more

04-08-2017

Procurement team and The Calvert Trust

As you know we have been working with The Calvert Trust which enables people with disabilities, together with their families and friends, to achieve their potential through the challenge of...

Read more

03-04-2017

Actavis UK & Ireland are now Accord Healthcare

Actavis UK & Ireland have rebranded to become Accord Healthcare

Read more

09-01-2017

Intas completes deal

Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses. 

Read more

21-12-2016

Imatinib Accord Launch

Accord Healthcare launches Imatinib Accord 100 mg and 400 mg in the UK.

Accord Healthcare launches Imatinib Accord[1] in the UK, a tyrosine-kinase inhibitor indicated for the treatment...

Read more

Pages